欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0792/003
药品名称SmofKabiven extra Nitrogen
活性成分
    • alanine 9.2 g
    • arginine 7.9 g
    • calcium chloride 0.28 g
    • fish oil, rich in omega 3-acids 4.3 g
    • glucose monohydrate 85.0 g
    • glycine 7.2 g
    • histidine 1.5 g
    • isoleucine 3.3 g
    • leucine 4.8 g
    • lysine 4.3 g
    • magnesium sulfate 0.61 g
    • medium-chain triglycerides 8.7 g
    • methionine 2.8 g
    • olive oil monohydrate 7.2 g
    • phenylalanine 3.3 g
    • potassium chloride 2.3 g
    • proline 7.3 g
    • serine 4.3 g
    • sodium glycerophosphate 2.3 g
    • sodium acetate 1.6 g
    • soybean oil monohydrate 8.7 g
    • taurine 0.65 g
    • threonine 2.9 g
    • tryptophan 1.3 g
    • tyrosine 0.26 g
    • valine 4.1 g
    • zinc sulfate 0.0 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB , Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      SmofKabiven Ntense
    • Denmark (DK)
    • Belgium (BE)
      SmofKabiven Extra Amino emulsie voor infusie
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      SmofKabiven extra Nitrogen Innrennslislyf, fleyti
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      SmofKabiven N-Plus zentral Emulsion zur Infusion
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
      SmofKabiven extra Nitrogen
    • Finland (FI)
    • Poland (PL)
      SmofKabiven extra Nitrogen
    • Latvia (LV)
    • Lithuania (LT)
      SmofKabiven extra Nitrogen infuzinė emulsija
    • Estonia (EE)
      SMOFKABIVEN EXTRA NITROGEN
    • Hungary (HU)
      SMOFKABIVEN N-PLUSZ emulziós infúzió
    • Bulgaria (BG)
    • Cyprus (CY)
      SMOFKABIVEN NTENSE
    • Czechia (CZ)
      SMOFKABIVEN EXTRA NITROGEN
    • Romania (RO)
      SMOFKABIVEN CENTRAL, emulsie perfuzabila
    • Slovakia (SK)
      SmofKabiven extra Nitrogen
    • Slovenia (SI)
    • Croatia (HR)
      SmofKabiven extra Nitrogen, emulzija za infuziju
许可日期2017/05/03
最近更新日期2024/04/22
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase